Impaired innate inflammatory response has a key role in the Crohn's disease (CD) pathogenesis. The aim of this study was to investigate the possible role of the TLR10-TLR1-TLR6 gene cluster in CD susceptibility. A total of 508 CD patients (284, cohort 1 and 224, cohort 2) and 576 controls were included. TLR10-TLR1-TLR6 cluster single-nucleotide polymorphisms genotyping, NOD2 mutations and TLR10 mRNA quantification were performed using TaqMan assays. Nucleotide-binding oligomerization domain containing 2 (NOD2) and Toll-like receptor (TLR) loci interaction was analyzed by logistic regression and multifactor-dimensionality reduction (MDR). Entropy-based analysis was used to interpret combination effects. One TLR10 haplotype (TLR10 GGGG ) was found associated with CD susceptibility in both cohorts, individuals with two copies had approximately twofold more risk of CD susceptibility than individuals having no copies (odds ratio ¼ 1.89, P-value ¼ 0.0002). No differences in the mRNA levels were observed among the genotypes. The strongest model for predicting CD risk according to the MDR analysis was a two-locus model including NOD2 mutations and TLR10 GGGG haplotype (P c o0.0001). The interaction gain attributed to the combination of both genes was negative (IG ¼ À2.36%), indicating redundancy or independent effects. Our results support association of the TLR10 gene with CD susceptibility. The effect of TLR10 would be independent of NOD2, suggesting different signaling pathways for both genes.
Introduction
Crohn's disease (CD) is an inflammatory bowel disease characterized by dysregulation of the mucosal immune response of the gut. 1 Although the exact etiology of CD remains unclear, accumulating data suggests that CD occurs from the combined effects of genetic predisposition and environmental factors. Thus, there is consensus that an inappropriate mucosal immune response to normal constituents of the intestinal microflora in genetically susceptible individuals is important in the pathogenesis of the disease. 2 The identification of nucleotide-binding oligomerization domain containing 2 (NOD2) as the first major susceptibility gene for CD provided important evidence of an impaired innate inflammatory response having a key role in the pathogenesis of CD. 3 The innate immune system is based on the ability to recognize pathogenassociated molecular patterns by pattern recognition receptors. NOD-like receptors are included among the pattern recognition receptors, together with many other molecules, such as Toll-like receptors (TLRs). 4 NOD2, also known as the CARD15 (caspase recruitment domain 15), is expressed mainly by Paneth cells, intestinal macrophages and dendritic cells, and it recognizes the muramyl dipeptide, which is a peptidoglycan constituent of the cell wall of both Gram-negative and Gram-positive bacteria, triggering nuclear factor-kB activation. 5 Within the NOD2 gene, three variants (Arg702Trp, Gly908Arg and Leu1007fsinsC) have been associated with susceptibility to CD. 6 Although, NOD2 is a major susceptibility gene for the disease, CD-associated NOD2 variants are absent in Asian populations 7 and, even in Europe, there is evidence of a north-south gradient in which the associated alleles have lower frequencies in Celtic and Scandinavian countries than in Southern Europe. 8 Other genes encoding molecules involved in innate inflammatory response, such as TRL4 and TLR9, have been related to susceptibility to CD. [9] [10] [11] TLRs are a family of transmembrane receptors that have a key role in immune response against microbial pathogens. In humans, the TLR family consists of 10 functional members (TLR1-TLR10), and they can be classified based on subcellular distribution into two groups, those located in intra-cellular compartments, such as the endosomes (TLR3,  TLR7, TLR8 and TLR9) and those generally expressed on  the cell surface (TLR1, TLR2, TLR4, TLR5, TLR6 and  TLR10) . Intracellular TLRs sense nucleic acid-based agonists and are particularly specialized in viral recognition, whereas cell-surface expressed TLRs detect other products, such as glycolipids, lipopeptides and flagellin, which are present in a large variety of organisms including bacteria, parasites and fungi. 12 Human TLR6, TLR1 and TLR10 genes are located within a 54-kb region on chromosome 4p14-encoding proteins that share a high degree of homology in their overall amino acid sequences.
13 TLR1 and TLR6 combine with TLR2-forming dimers to recognize pathogen-associated molecular patterns. TLR1-TLR2 recognize peptidoglycans from Gram-positive bacteria and zymosan from yeast cell walls, whereas TLR2-TLR6 recognize the lipoproteins from Mycoplasma.
14 TLR10 remains as the only orphan member among the human TLRs, and it is highly expressed in B-cell lines, peripheral B cells and plasmacytoid dendritic cells from tonsil. 15 Four mRNA isoforms have been identified, but all encode the same protein (http://www.ncbi.nlm.nih.gov/sites/entrez). Variations within the TLR10-TLR1-TLR6 gene cluster have been associated with several diseases, including asthma, 16, 17 prostate cancer, 18 nasopharyngeal carcinoma, 19 non-Hodgkin lymphoma, 20 Lyme disease 21 and atherogenesis. 22 However, association between the TLR10-TLR1-TLR6 gene cluster and CD has not been yet studied. In the present work, we have investigated the possible role of this gene cluster in susceptibility to CD. Table 1 shows the frequencies of the 11 tag singlenucleotide polymorphisms (SNPs) studied in the two CD patient cohorts and healthy controls. The study population was found to be in the Hardy-Weinberg equilibrium for all the polymorphisms analyzed (P40.05). No statistically significant differences (permutation P-value (P c )40.05) in the distribution of the allelic frequencies were observed on comparing CD patients and controls for any of the 11 SNPs. However, in cohort 1, two of them, rs7658893 and rs7653908, located in the intron 1 of the TLR10 were found to be associated before P-correction (P ¼ 0.0058 and P ¼ 0.029, respectively). Nevertheless, this association could not be confirmed in cohort 2, although the trend was the same for both SNPs.
Results
In the haplotype analysis, no haplotype was found to be associated with CD when the complete region from TLR10 to TLR6 was included (data not shown). Nevertheless, on considering the different TLR regions: TLR10, TLR1 and TLR6 independently, a statistically significant higher frequency of one haplotype block constituted by the four SNPs included in the TLR10 region (TLR10 GGGG ) was found in both patient cohorts (cohort 1: 0.506, and cohort 2: 0.493) on comparing with controls (0.416, P c ¼ 0.0022 and P c ¼ 0.025, respectively) ( Table 2 ). We estimated the CD risk associated with the doses of the TLR10 GGGG haplotype; individuals with two copies of the TLR10 GGGG haplotype showed twofold more risk of susceptibility to CD than the individuals having no copies, both in cohort 1 (odds ratio (OR) ¼ 1.9, 95% confidence interval ¼ 1.32-2.88, P ¼ 0.0008) and cohort 2 (OR ¼ 1.81, 95% confidence interval 1.17-2.82, P ¼ 0.0077) (Table 3a) . Case-only phenotype analysis of CD patients revealed no association between TLR10 GGGG haplotype and mean age at diagnosis, disease location or disease behavior (data not shown). A relative quantification of mRNA encoding the TLR10 isoforms 1 and 2 was performed in CD19 þ cells from healthy controls stratified according to their TLR10 GGGG genotypes ( þ / þ , þ /À and À/À). No statistically significant differences in the mRNA levels of the isoforms 1 and 2 were observed among these TLR10 GGGG genotypes ( Table 4) .
As the presence of mutations in the NOD2 gene is a risk factor in the susceptibility to CD, we also analyzed the frequency of CD-associated NOD2 variants in our CD cohort and control population (Table 3b) . As was expected, the presence of mutations in both NOD2 genes The contribution of NOD2 mutations and TLR10 GGGG haplotype to CD susceptibility was evaluated in the overall cohorts 1 and 2, using a logistic regression model. Patients and controls were classified into nine groups defined by the presence of 0, 1 and 2 copies of both NOD2 mutations and TLR10 GGGG haplotype (Table 5) . Individuals with zero copies of TLR10 GGGG haplotype and without NOD2 mutations were used as a reference group. According to our results, in the group without NOD2 mutations, individuals with two copies of the TLR10 GGGG haplotype showed a statistically significant higher risk of susceptibility to CD than individuals having no copies (OR ¼ 1.78, P ¼ 0.0024), whereas individuals with only one copy of the TLR10 GGGG haplotype did not have an increased risk of susceptibility to CD. Nevertheless, among the group of individuals with one NOD2 mutation, individuals bearing one as well as two copies of the TLR10 GGGG haplotype had an increased risk Testing different genetic models of inheritance for TLR10 GGGG haplotype, we found that the dominant model could be excluded, whereas the recessive model was the best-fitting among individuals without NOD2 mutations, (likelihood ratio ¼ 7.5546, P ¼ 0.005986) (Table 6a ). Regarding the group with one NOD2 mutation, although it was not possible to discard any model, the multiplicative model seems to be the best-fitting (likelihood ratio ¼ 15.7590, P ¼ 0.000072) (Table 6b) .
To complement logistic regression analyses, multifactor-dimensionality reduction (MDR) software was used to further evaluate gene-gene interactions associated with CD. Analysis was performed with the NOD2 mutations, TLR10 GGGG haplotype and the 11 SNPs included in this study. The NOD2 locus was identified as the best single predictor factor of CD susceptibility (average testing accuracy (ATA) ¼ 0.5997, P c o0.0001), and NOD2 and TLR10 GGGG haplotype as the best twolocus model (ATA ¼ 0.6137, P c o0.0001) ( Table 7) .
On analyzing whether the observed interaction between both attributes, NOD2 and TLR10 GGGG, had or did not have a synergistic effect, we found an interaction gain value negative (IG ¼ À2.36%) ( Table 8 ). This negative value is because the percentage of entropy removed by the interaction of both attributes, NOD2 and TLR10 GGGG was 3.97% less than the sum of the percentage of entropy removed by each attribute (5.38% and 0.95%, respectively). This result suggests that the interaction of both genes have redundancy or independent effects.
Discussion
This work constitutes the first attempt in establishing a relationship between TLR10 and susceptibility to CD. As the identification of NOD2/CARD15 as the first susceptibility gene for CD, an intriguing hypothesis was raised, suggesting that genetic variations in other receptors of the innate immune system may contribute to CD susceptibility. Genome-wide association studies have identified multiple susceptibility loci involved in the genetic susceptibility to CD, 23, 24 and they have confirmed the main role of the innate immunity in the disease. However, these loci explain about only the 10% of the overall variance in disease risk, which may be as much as a fifth of the genetic risk, suggesting that many additional loci are yet to be identified. 23 Genome-wide association platforms used in CD susceptibility studies included only one of the SNPs genotyped in our study, the rs10024216, which was not found to be associated with CD in any of the two cohorts of the present study. The other SNPs studied in these platforms span a region located between rs10024216 and rs7653908. On the other TLR10 and Crohn's disease C Abad et al hand, the genome-wide association studies arrays did not offer complete genome coverage of common variations, they did not address either rare SNPs or copy number variation effectively, and they did not permit haplotype studies. Several works have reported association of CD susceptibility with other pattern recognition receptors, such as TLR4 (ref. 9) and TLR9. 10, 11 In this work, we explored association of CD with the TLR10-TLR1-TLR6 gene cluster by constructing haplotype blocks, taking into account the SNP haplotypes found in CEU in the HapMap Project. Using this approach, we have defined one haplotype in TLR10 gene (named TLR GGGG ), associated with CD susceptibility, obtaining similar results in two patient cohorts. According to our results, individuals with two copies of this haplotype would have a similar risk to susceptibility as individuals with one mutation in the NOD2 gene (OR ¼ 1.78 and OR ¼ 2.24, respectively). To explore the possible relationship between presence of the risk haplotype and mRNA expression, mRNA levels of the two most common TLR10 isoforms were quantified in B cells from healthy donors stratified according to their TLR10 genotypes. The sample size included in the expression study is low, but differences in the B-cells mRNA levels attributable to the TLR10 genotypes were not found. Therefore, although differences in the mRNA levels of the other two lesser common isoforms cannot be excluded, association between TLR10 and CD disease could be related with other factors such as differences in the 3 0 -untranslated region influencing post-transcriptional control or differences in the protein sequence of the different genotypes affecting its function.
As NOD2 is a factor related to innate immunity with a contribution to CD well established, we analyzed the contribution of the TLR10 GGGG haplotype in relation to NOD2 using a logistic regression method. This model suggests that two copies of the risk factor would be necessary to contribute to CD susceptibility whether mutations in other genes are absent (subjects carrying zero copies of NOD2 mutations), whereas the TLR10 GGGG haplotype could be an additional risk factor if mutations in other genes are present (subjects with one copy of NOD2 mutations). The analysis of inheritance models suggests a similar conclusion because a recessive and a multiplicative model were found to be the bestfitting models when the groups of zero and one NOD2 mutations, respectively, were considered. Owing to the high OR conferred by two mutations of the NOD2 gene, it was impossible to evaluate the risk to TLR10 GGGG haplotype in this group of subjects.
Recent reports suggest epistatical interactions between NOD2 and other receptors of the innate immune systemmodulating inflammatory responses. Therefore, in others, to better study the interaction between NOD2 and TLR10, we used the MDR method. 25, 26 MDR is a nonparametric and model-free method alternative to logistic regression that is effective with relatively small sample sizes. According to the MDR analysis, the two-locus model, including NOD2 mutations and TLR10 GGGG haplotype, had an improved accuracy (proportion of individuals that are correctly classified as patients and controls) for predicting CD risk than the one-locus NOD2 mutations model (ATA ¼ 0.6137 and ATA ¼ 0.5997, respectively). On the other hand, the interaction entropy analysis revealed no statistical epistasis between NOD2 mutations and TLR10 GGGG haplotype (IG ¼ À2.36%). Therefore, although an absence of statistical epistasis does not necessarily imply absence of biological epistasis, our results suggest a non-synergic effect between both loci. Biological epistasis is the result of physical interactions among biomolecules within gene regulatory networks and biochemical pathways. 27 NOD2 activation by protein-glycan 5 initializes a cascade of signaling inducing nuclear factor-kb, but NOD2 also triggers interferon-b expression by recognizing single-stranded RNA virus. 28 Statistical epistatis between TLR9 and NOD2 loci has been described 11 and this relationship is likely to be based on biological epistasis because NOD2 stimulation normally enhances innate immune responses to CpG DNA, which is sensed through TLR9 (ref. 29) inducing both genes the nuclear factor-kb signaling pathways. Nevertheless, with respect to TLR10, Guan et al. 30 recently demonstrated that, although TLR10 is a partner for TLR2 on the cell surface and it shares a variety of agonist with TLR1, however, it fails to activate the typical TLR-induced signaling including nuclear factor-kb and interferon-b. These data suggest that NOD2 and TLR10 have different signaling pathways, which would explain the independent effects of both loci in the susceptibility to CD.
In conclusion, although these data need replication in other cohorts, our results suggest a relationship between TLR10 and Crohn's disease C Abad et al the TLR10 gene and the susceptibility to CD. This effect would be independent to association of the disease with NOD2 variants. ( Table 9 ). The control population consisted of 576 ethnically matched healthy unrelated bone marrow donors. The study was approved by all local ethics committees of the corresponding hospitals. Blood samples were obtained from subjects after they provided written informed consent. Genomic DNA was extracted from blood leukocytes using QIAmp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's recommendations and stored at À201C.
Subjects and methods

Subjects
TLR10-TLR1-TLR6 SNPs genotyping
Eleven tag SNPs for TLR10 (rs6841698, rs10024216, rs7653908, rs7658893), TLR 1 (rs5743604, rs5743594, rs5743563, rs4833103) and TLR6 (rs5743810, rs1504239, rs6531672) were selected from the designated set of common SNPs (minor allele frequency X0. 
Quantification of mRNA TLR10
The TLR10 mRNA expression assays were performed using 43 samples from healthy donors. Gender distribution in this selected group was 1:1, and no significant differences regarding age were detected between these samples and the rest of the controls or patients. B cells (CD19 þ ) were isolated by Macs System (Miltenyi Biotec, Barcelona, Spain) from 2 Â 10 8 mononuclear cells obtained using a ficoll centrifugation gradient. Quantification of mRNA was performed on a 7500 Fast RealTime PCR System using two TaqMan Gene Expression Assays (Applied Biosystems). The Hs01675179_ m1 assay, which spans exon 1-2 splice junctions was used to detect TLR10 isoform 1, and the Hs00999403_m1 assay, which spans exon 1-4 splice junctions was used to detect the isoform 2. The mRNA expression of TLR10 was correlated with the mRNA expression of the housekeeping gene, ABL. Condition assays and data analysis have been previously described. 33 Each sample was tested in triplicate and only samples showing ABL Cp values between 24 and 30 and a s.d. of Cpo0.3 were included in the final analysis (n ¼ 40).
Statistical analysis
Allele and haplotype frequency distributions were compared using the w 2 -test, and a P c value was calculated from 10 000 permutations (Haploview version 4). Those P c -values o0.05 were considered statistically significant. The ORs with their corresponding 95% confidence intervals were calculated for each genotype using a logistic regression (Epi Info version 3.5.1; Centers for Disease Control and Prevention, Atlanta, GA, USA) in which those individuals who carried presumed low-risk genotypes were used as reference group. Results of relative mRNA expression are showed as mean ± s.d. Statistical analysis was performed using the analysis of variance test (Epi Info) because the variances were homogeneous (Barlett's test P40.05).
The Akaike information criterion 34 was used to determine the genetic model of inheritance using the Chaplin software 35 (available at the website http:// www.genetics.emory.edu/labs/epstein/software/chaplin). According to this analysis, four models are possible. Subjects with one copy of the risk haplotype have (1) in the recessive model the same risk as those subjects with no copies; (2) in the dominant model the same risk as TLR10 and Crohn's disease C Abad et al those subjects with two copies; (3) in the multiplicative model an intermediate risk on log scale with respect to those subjects with zero or two copies; and (4) in the general model a general change in risk compared to those with zero or two copies. Gene-gene interactions were evaluated using the nonparametric MDR method. [25] [26] A 10-fold cross-validation was used to estimate the ATA and cross-validation consistency of MDR models. The MDR model with the highest ATA and cross-validation consistency was selected as the best model. Statistical significance was evaluated using 10 000-fold permutation test.
To interpret combination effects identified by logistic regression and MDR, an entropy-based analysis was used. Interaction entropy uses information gain to gauge whether interactions between two (or more) variables considered independent exist. 36 Entropy is estimated for each individual attribute (that is, main effects) and each pairwise combination of attributes (that is, interaction effects). Therefore, the main effects of each factor can be compared with the interaction effect to determine whether interactions are additive or non-additive. There is evidence for a synergistic interaction when a positive value is obtained combining two (or more) variables. Conversely, there are redundancy or independent effects when a negative value is obtained by loss of information. 36 
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